Nanowear In The News

Neural networks and feature-based machine learning: The evolution of applications in Healthcare and Medtech

Nanowear has published an article on The Launchpad, Google's publication for applied-Machine Learning (ML) best practices from the trenches, on the factors that Healthcare and Medtech teams need to consider when deciding between a neural network or feature-based approach to their AI and ML strategy.
Read the article on The Launchpad

Nanowear Announces Clinical Launch of NanoSENSE, a Heart Failure Management and Alert Diagnostic Validation Study

NEW YORK, NY, July 22, 2019 — Nanowear, the leading nanotechnology-based connected-care and remote monitoring platform, today announced the clinical launch of NanoSENSE, a Heart Failure Management and Alert Diagnostic Validation Study. The study will initially be conducted at Penn State Milton S. Hershey Medical Center and Hackensack Meridian Health Systems.
Read the full press release

Planning for Machine Learning as a Medtech Startup

Nanowear co-founder and CEO Venk Varadan authored a piece for The Launchpad, Google's publication for applied-Machine Learning (ML) best practices from the trenches, on planning for machine learning as a medtech startup. The essay describes the work involved to find the right combination of approach, tools, infrastructure, and team as a company defines and scales it's application of machine learning.
Read the article on The Launchpad

Nanowear Receives FDA Clearance For Its Transformative Remote Diagnostic Monitoring Device Differentiated By Novel Cloth-Based Nanosensor Technology (SimplECG™)

NEW YORK, NY, December 1, 2016 — Nanowear, an early stage developer of cloth-based diagnostic monitoring nanosensor technology, today announced that it has received FDA Class II 510(k) clearance for its first product, SimplECG™, a remote cardiac monitoring undergarment. SimplECG™ collects continuous multi-channel ECG, heart rate and respiratory rate data from the garment and transfers it to a web-based portal for review by a physician, by way of a mobile application. The initial version of the product is iPhone-based.
Read the full press release

Nanowear Appoints Industry-Leading Experts To Its Newly Formed Advisory Board

NEW YORK, NY, December 10, 2014 — Nanowear, an emerging developer of wearable, textile-based diagnostic monitoring technology, today announced the appointment of leading medical and technology experts to its newly formed Advisory Board. The newly appointed Advisory Board will serve as a strategic resource to Nanowear as the Company continues product development and quality management in preparation for the U.S. Food and Drug Administration (FDA) approval process of its go-to-market product, a remote cardiac monitoring shirt for patients exhibiting symptoms of cardiovascular disease and potential ischemic events.
Read the full press release

Nanowear Raises $1.5M Led By Social+Capital And MAS Holdings To Disrupt Remote Medical Diagnostic Monitoring

NEW YORK, NY, September 10, 2014 — Nanowear Inc., an early-stage developer of wearable, textile-based diagnostic monitoring technology, today announced a $1.5M seed investment led by The Social+Capital Partnership and MAS Holdings (Pvt.) Limited, with several influential angels also participating in the round. The seed investment will fund production scaling and continued testing / validation of the company’s go-to-market product, a remote cardiac monitoring wearable base layer, in preparation for the U.S. Food and Drug Administration’s (FDA) approval process.
Read the full press release